Potential Therapeutic Use of Stem Cells for Prion Diseases

Prion diseases are neurodegenerative disorders that are progressive, incurable, and deadly. The prion consists of PrPSc, the misfolded pathogenic isoform of the cellular prion protein (PrPC). PrPC is involved in a variety of physiological functions, including cellular proliferation, adhesion, differentiation, and neural development. Prion protein is expressed on the membrane surface of a variety of stem cells (SCs), where it plays an important role in the pluripotency and self-renewal matrix, as well as in SC differentiation. SCs have been found to multiply the pathogenic form of the prion protein, implying their potential as an in vitro model for prion diseases. Furthermore, due to their capability to self-renew, differentiate, immunomodulate, and regenerate tissue, SCs are prospective cell treatments in many neurodegenerative conditions, including prion diseases. Regenerative medicine has become a new revolution in disease treatment in recent years, particularly with the introduction of SC therapy. Here, we review the data demonstrating prion diseases’ biology and molecular mechanism. SC biology, therapeutic potential, and its role in understanding prion disease mechanisms are highlighted. Moreover, we summarize preclinical studies that use SCs in prion diseases.

[1]  M. Zabel,et al.  Intranasally delivered mesenchymal stromal cells decrease glial inflammation early in prion disease , 2023, Frontiers in Neuroscience.

[2]  R. Bolea,et al.  Susceptibility of Ovine Bone Marrow-Derived Mesenchymal Stem Cell Spheroids to Scrapie Prion Infection , 2023, Animals : an open access journal from MDPI.

[3]  S. Kook,et al.  Prion infection modulates hematopoietic stem/progenitor cell fate through cell-autonomous and non-autonomous mechanisms , 2023, Leukemia.

[4]  Cheng-I Lee,et al.  Combination of structure-based virtual screening, molecular docking and molecular dynamics approaches for the discovery of anti-prion fibril flavonoids , 2023, Frontiers in Molecular Biosciences.

[5]  M. Zabel,et al.  Adipose-derived mesenchymal stromal cells decrease prion-induced glial inflammation in vitro , 2022, Scientific Reports.

[6]  K. Shim,et al.  Prion therapeutics: Lessons from the past , 2022, Prion.

[7]  R. Nonno,et al.  An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein , 2022, The Journal of biological chemistry.

[8]  M. Bolognesi,et al.  Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models. , 2022, European journal of medicinal chemistry.

[9]  Zhizhong Shang,et al.  Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials , 2022, BMC Medicine.

[10]  B. Jeong,et al.  Creutzfeldt-Jakob Disease Incidence, South Korea, 2001–2019 , 2022, Emerging infectious diseases.

[11]  M. Heke,et al.  Stem cell-based therapy for human diseases , 2022, Signal Transduction and Targeted Therapy.

[12]  Milad Shirvaliloo,et al.  The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment , 2022, Stem cell research & therapy.

[13]  Mengqin Yuan,et al.  Mesenchymal stromal cells: promising treatment for liver cirrhosis , 2022, Stem Cell Research & Therapy.

[14]  Jinqiu Zhang,et al.  Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? , 2022, Cell Death & Disease.

[15]  D. Dafou,et al.  Carnosic Acid and Carnosol Display Antioxidant and Anti-Prion Properties in In Vitro and Cell-Free Models of Prion Diseases , 2022, Antioxidants.

[16]  B. Caughey,et al.  Real-Time Quaking- Induced Conversion Assays for Prion Diseases, Synucleinopathies, and Tauopathies , 2022, Frontiers in Aging Neuroscience.

[17]  M. Bolognesi,et al.  Therapeutic strategies for identifying small molecules against prion diseases , 2022, Cell and Tissue Research.

[18]  B. Jeong,et al.  In-depth examination of PrPSc in Holstein cattle carrying the E211K somatic mutation of the bovine prion protein gene (PRNP). , 2021, Transboundary and emerging diseases.

[19]  Yong-Chan Kim,et al.  Altered expression of glymphatic system-related proteins in prion diseases: Implications for the role of the glymphatic system in prion diseases , 2021, Cellular & Molecular Immunology.

[20]  S. Méndez-Ferrer,et al.  Cellular Heterogeneity of Mesenchymal Stem/Stromal Cells in the Bone Marrow , 2021, Frontiers in Cell and Developmental Biology.

[21]  M. Nakashima,et al.  Characterization of stable hypoxia-preconditioned dental pulp stem cells compared with mobilized dental pulp stem cells for application for pulp regenerative therapy , 2021, Stem Cell Research & Therapy.

[22]  R. Bolea,et al.  Effect of Scrapie Prion Infection in Ovine Bone Marrow-Derived Mesenchymal Stem Cells and Ovine Mesenchymal Stem Cell-Derived Neurons , 2021, Animals : an open access journal from MDPI.

[23]  Caihong Zhu,et al.  Neuroinflammation in Prion Disease , 2021, International journal of molecular sciences.

[24]  M. Nakashima,et al.  Characterization of stable hypoxia-preconditioned dental pulp stem cells compared with mobilized dental pulp stem cells for application for pulp regenerative therapy , 2021, Stem cell research & therapy.

[25]  M. Krampera,et al.  Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells , 2020, Frontiers in Cell and Developmental Biology.

[26]  A. A. Galiakberova,et al.  Neural Stem Cells and Methods for Their Generation From Induced Pluripotent Stem Cells in vitro , 2020, Frontiers in Cell and Developmental Biology.

[27]  V. Tkachuk,et al.  Mesenchymal Stromal Cells as Critical Contributors to Tissue Regeneration , 2020, Frontiers in Cell and Developmental Biology.

[28]  Lei Lei,et al.  Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine , 2020, Stem Cell Reviews and Reports.

[29]  Lin-Po Yang,et al.  Stem cell therapy for Alzheimer's disease , 2020, World journal of stem cells.

[30]  K. Iohara,et al.  Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019 , 2020, Cell transplantation.

[31]  Zunjin Liu,et al.  Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials , 2020, Stem Cell Research & Therapy.

[32]  F. Santilli,et al.  Prion Protein in Stem Cells: A Lipid Raft Component Involved in the Cellular Differentiation Process , 2020, International journal of molecular sciences.

[33]  Suleiman Yusuf Alhaji,et al.  Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy , 2020, BioResearch open access.

[34]  F. Rizzo,et al.  Neural Stem Cell Transplantation for Neurodegenerative Diseases , 2020, International journal of molecular sciences.

[35]  M. Bolognesi,et al.  In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives. , 2020, European journal of medicinal chemistry.

[36]  Baoan Chen,et al.  Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease , 2020, Cancer Cell International.

[37]  S. Chand,et al.  Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications , 2020, Frontiers in Cell and Developmental Biology.

[38]  Maximilian T. Strauss,et al.  Cellular models for discovering prion disease therapeutics: Progress and challenges , 2020, Journal of neurochemistry.

[39]  I. Zerr,et al.  Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency , 2019, Molecular Neurobiology.

[40]  S. Schreiber,et al.  Antisense oligonucleotides extend survival of prion-infected mice , 2019, JCI insight.

[41]  Hyung-Sik Kim,et al.  Current Strategies to Enhance Adipose Stem Cell Function: An Update , 2019, International journal of molecular sciences.

[42]  Yanbo Zhang,et al.  Mesenchymal Stem Cells for Regenerative Medicine , 2019, Cells.

[43]  P. Peláez,et al.  Adipose-Derived Mesenchymal Stem Cells: A Promising Tool in the Treatment of Musculoskeletal Diseases , 2019, International journal of molecular sciences.

[44]  D. Harris,et al.  Prion neurotoxicity , 2019, Brain pathology.

[45]  M. D. Di Bari,et al.  Full restoration of specific infectivity and strain properties from pure mammalian prion protein , 2019, PLoS pathogens.

[46]  Wojciech Zakrzewski,et al.  Stem cells: past, present, and future , 2019, Stem cell research & therapy.

[47]  R. Chiesa,et al.  Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds. , 2019, Current opinion in pharmacology (Print).

[48]  Taeyoung Kang,et al.  Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles , 2018, Nucleic Acids Res..

[49]  A. Aguzzi,et al.  Prions, prionoids and protein misfolding disorders , 2018, Nature Reviews Genetics.

[50]  V. Cavalli,et al.  Intrinsic mechanisms of neuronal axon regeneration , 2018, Nature Reviews Neuroscience.

[51]  M. Ghahremani,et al.  Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine , 2018, Stem Cell Research & Therapy.

[52]  F. Santilli,et al.  Role of Prion protein-EGFR multimolecular complex during neuronal differentiation of human dental pulp-derived stem cells , 2018, Prion.

[53]  V. Cecchetti,et al.  Pharmacological Agents Targeting the Cellular Prion Protein , 2018, Pathogens.

[54]  S. Chandran,et al.  Human stem cell–derived astrocytes replicate human prions in a PRNP genotype–dependent manner , 2017, The Journal of experimental medicine.

[55]  M. Horiuchi,et al.  Therapeutic effect of autologous compact bone-derived mesenchymal stem cell transplantation on prion disease. , 2017, The Journal of general virology.

[56]  D. Dufrane Impact of Age on Human Adipose Stem Cells for Bone Tissue Engineering , 2017, Cell transplantation.

[57]  A. Castle,et al.  Physiological Functions of the Cellular Prion Protein , 2017, Front. Mol. Biosci..

[58]  J. Frydman,et al.  Protein misfolding in neurodegenerative diseases: implications and strategies , 2017, Translational Neurodegeneration.

[59]  M. Dhar,et al.  Donor-Matched Comparison of Chondrogenic Potential of Equine Bone Marrow- and Synovial Fluid-Derived Mesenchymal Stem Cells: Implications for Cartilage Tissue Regeneration , 2017, Front. Vet. Sci..

[60]  S. Y. Kim,et al.  Anti-Prion Screening for Acridine, Dextran, and Tannic Acid using Real Time–Quaking Induced Conversion: A Comparison with PrPSc-Infected Cell Screening , 2017, PloS one.

[61]  S. Brandner,et al.  Prion disease: experimental models and reality , 2017, Acta Neuropathologica.

[62]  B. Caughey,et al.  Diagnostic and prognostic value of human prion detection in cerebrospinal fluid , 2017, Annals of neurology.

[63]  S. Pluchino,et al.  Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis , 2016, Journal of Neuroimmunology.

[64]  G. Baron,et al.  PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection , 2016, Journal of Virology.

[65]  M. Dhar,et al.  Effects of pro-inflammatory cytokines on chondrogenesis of equine mesenchymal stromal cells derived from bone marrow or synovial fluid. , 2016, Veterinary journal.

[66]  S. Guan,et al.  Optimization of Aryl Amides that Extend Survival in Prion-Infected Mice , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[67]  Ankur A Patel,et al.  Stem Cell Therapy for Alzheimer's Disease , 2016, 1608.07499.

[68]  D. Varges,et al.  Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie , 2016, Scientific Reports.

[69]  H. Tse,et al.  Mesenchymal stem cells and immunomodulation: current status and future prospects , 2016, Cell Death and Disease.

[70]  S. Guan,et al.  Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse Brains , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[71]  Mingfen Li,et al.  Mesenchymal stem cells suppress CD8+ T cell‐mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3‐dioxygenase and transforming growth factor‐β , 2014, Clinical and experimental immunology.

[72]  Derek H. Oakley,et al.  Stem cells in the nervous system. , 2014, American journal of physical medicine & rehabilitation.

[73]  H. Tse,et al.  Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives , 2014, Cell transplantation.

[74]  S. Prusiner,et al.  Mouse Models for Studying the Formation and Propagation of Prions* , 2014, The Journal of Biological Chemistry.

[75]  Yong-Sun Kim,et al.  Genetic Studies in Human Prion Diseases , 2014, Journal of Korean medical science.

[76]  P. Pascutti,et al.  Anti-Prion Activity of a Panel of Aromatic Chemical Compounds: In Vitro and In Silico Approaches , 2014, PloS one.

[77]  Camilo Duque Velásquez,et al.  Infectious Prions Accumulate to High Levels in Non Proliferative C2C12 Myotubes , 2013, PLoS pathogens.

[78]  Zhe Li,et al.  Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[79]  S. Prusiner,et al.  Drug resistance confounding prion therapeutics , 2013, Proceedings of the National Academy of Sciences.

[80]  P. Fischer,et al.  Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice , 2013, Science Translational Medicine.

[81]  A. Gabelle,et al.  Prion Replication Occurs in Endogenous Adult Neural Stem Cells and Alters Their Neuronal Fate: Involvement of Endogenous Neural Stem Cells in Prion Diseases , 2013, PLoS pathogens.

[82]  C. Simmons,et al.  Mesenchymal stem cell mechanobiology and emerging experimental platforms , 2013, Journal of The Royal Society Interface.

[83]  M. Hoogduijn,et al.  Mesenchymal Stem Cells: Are We Ready for Clinical Application in Transplantation and Tissue Regeneration? , 2013, Front. Immunol..

[84]  F. Djouad,et al.  Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells , 2013, Stem Cell Research & Therapy.

[85]  R. Bolea,et al.  Isolation and characterization of ovine mesenchymal stem cells derived from peripheral blood , 2012, BMC Veterinary Research.

[86]  W. Keith,et al.  A Small Molecule Modulator of Prion Protein Increases Human Mesenchymal Stem Cell Lifespan, Ex Vivo Expansion, and Engraftment to Bone Marrow in NOD/SCID Mice , 2012, Stem cells.

[87]  R. Xu,et al.  Concise Review: Genomic Stability of Human Induced Pluripotent Stem Cells , 2012, Stem cells.

[88]  J. Torres,et al.  Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner. , 2011, The Journal of infectious diseases.

[89]  H. Furuoka,et al.  Identification of Chemoattractive Factors Involved in the Migration of Bone Marrow-Derived Mesenchymal Stem Cells to Brain Lesions Caused by Prions , 2011, Journal of Virology.

[90]  S. Böhm,et al.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.

[91]  J. Choi,et al.  Reduction of Prion Infectivity and Levels of Scrapie Prion Protein By Lithium Aluminum Hydride: Implications for RNA in Prion Diseases , 2009, Journal of neuropathology and experimental neurology.

[92]  J. Castilla,et al.  In Vivo Generation of Neurotoxic Prion Protein: Role for Hsp70 in Accumulation of Misfolded Isoforms , 2009, PLoS genetics.

[93]  B. Lo,et al.  Ethical issues in stem cell research. , 2009, Endocrine reviews.

[94]  H. Furuoka,et al.  Effect of Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells on Mice Infected with Prions , 2009, Journal of Virology.

[95]  J. Kira,et al.  Bone marrow stroma cells are susceptible to prion infection. , 2008, Biochemical and biophysical research communications.

[96]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[97]  A. Aguzzi,et al.  The prion's elusive reason for being. , 2008, Annual review of neuroscience.

[98]  Joel S Greenberger,et al.  Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblasts , 2008, Aging cell.

[99]  I. Izquierdo,et al.  Physiology of the prion protein. , 2008, Physiological reviews.

[100]  C. Julius,et al.  Prion strain discrimination in cell culture: The cell panel assay , 2007, Proceedings of the National Academy of Sciences.

[101]  F. Cohen,et al.  Cell division modulates prion accumulation in cultured cells , 2007, Proceedings of the National Academy of Sciences.

[102]  K. Doh-ura,et al.  Orally Administered Amyloidophilic Compound Is Effective in Prolonging the Incubation Periods of Animals Cerebrally Infected with Prion Diseases in a Prion Strain-Dependent Manner , 2007, Journal of Virology.

[103]  M. Horiuchi,et al.  Characterization of Prion Susceptibility in Neuro2a Mouse Neuroblastoma Cell Subclones , 2007, Microbiology and immunology.

[104]  S. Jacchieri,et al.  Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins , 2007, Journal of Cell Science.

[105]  D. Harris,et al.  The cellular prion protein (PrP(C)): its physiological function and role in disease. , 2007, Biochimica et biophysica acta.

[106]  H. Schätzl,et al.  Antibodies to a Nonconjugated Prion Protein Peptide 95-123 Interfere with PrPSc Propagation in Prion-Infected Cells , 2007, Cellular and Molecular Neurobiology.

[107]  M. Shinagawa,et al.  Microglial Cell Line Established from Prion Protein-Overexpressing Mice Is Susceptible to Various Murine Prion Strains , 2006, Journal of Virology.

[108]  R. McKay,et al.  Neural Stem Cell Model for Prion Propagation , 2006, Stem cells.

[109]  Anoop P. Patel,et al.  Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. , 2006, Blood.

[110]  D. Westaway,et al.  The Expanding Universe of Prion Diseases , 2006, PLoS pathogens.

[111]  Andrew D. Steele,et al.  Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[112]  Andrew D. Steele,et al.  Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[113]  R. Linden,et al.  Interaction of Cellular Prion and Stress-Inducible Protein 1 Promotes Neuritogenesis and Neuroprotection by Distinct Signaling Pathways , 2005, The Journal of Neuroscience.

[114]  Neil R. Cashman,et al.  Prion diseases — close to effective therapy? , 2004, Nature Reviews Drug Discovery.

[115]  A. Aguzzi,et al.  Mammalian Prion Biology One Century of Evolving Concepts , 2004, Cell.

[116]  Sebastian Brandner,et al.  Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis , 2003, Science.

[117]  J. Cesbron,et al.  PrP Expression and Replication by Schwann Cells: Implications in Prion Spreading , 2002, Journal of Virology.

[118]  J. Fraser,et al.  Fetal cell grafts provide long-term protection against scrapie induced neuronal loss , 2001, Neuroreport.

[119]  A. Favier,et al.  Prion infection impairs the cellular response to oxidative stress. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[120]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[121]  D. Harris,et al.  Successful Transmission of Three Mouse-Adapted Scrapie Strains to Murine Neuroblastoma Cell Lines Overexpressing Wild-Type Mouse Prion Protein , 2000, Journal of Virology.

[122]  Y. Kim,et al.  Molecular analysis of prion protein gene (PRNP) in Korean patients with Creutzfeldt-Jakob disease. , 1998, Journal of Korean medical science.

[123]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[124]  A. Aguzzi,et al.  Normal host prion protein necessary for scrapie-induced neurotoxicity , 1996, Nature.

[125]  R. Colello,et al.  Developmental expression of the prion protein gene in glial cells , 1995, Neuron.

[126]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[127]  N. Cashman,et al.  Nearly ubiquitous tissue distribution of the scrapie agent precursor protein , 1992, Neurology.

[128]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[129]  A. Friedenstein,et al.  Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers , 1987, Cell and tissue kinetics.

[130]  Ludmila Buravkova Mesenchymal stromal cells (MSCs) , 2020 .

[131]  I. Zerr,et al.  Amplification and Detection of Minuscule Amounts of Misfolded Prion Protein by Using the Real-Time Quaking-Induced Conversion. , 2018, Methods in molecular biology.

[132]  M. Ciuffreda,et al.  Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair. , 2016, Methods in molecular biology.

[133]  Claudio Soto,et al.  The intricate mechanisms of neurodegeneration in prion diseases. , 2011, Trends in molecular medicine.

[134]  C. Masters,et al.  Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture. , 2008, The international journal of biochemistry & cell biology.

[135]  C. Zurzolo,et al.  Prions , 2007, Journal of Molecular Neuroscience.

[136]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[137]  S. Prusiner,et al.  Scrapie prion proteins are synthesized in neurons. , 1986, The American journal of pathology.